Sarchielli P, Galli F, Floridi Ar, Floridi Al, Gallai V
Neuroscience Department, Neurological Clinic, University of Perugia, Italy. neuro.pg@tiscalinet-it
Amino Acids. 2003 Dec;25(3-4):427-36. doi: 10.1007/s00726-003-0028-6. Epub 2003 Aug 21.
This review has focused on the evidence for the involvement of nitrative oxidation in certain neurodegenerative disorders (Parkinson's Disease, Alzheimer's Disease, Amyotrophic Lateral Sclerosis), stroke, and inflammatory and autoimmune disorders (with particular attention devoted to multiple sclerosis). The relationship between protein peroxidation and pathological changes observed in the above disorders has been reported. Whereas many of the findings are from studies with animal models and autoptic specimens from human patients, few data are available from cerebrospinal fluid and blood samples of the patients at different times and disease stages. The participation of nitrative oxidation to the direct and indirect injury of neurons and other cells of the brain (i.e., oligodendrocytes, for multiple sclerosis) is clear; less evident is their relevance for the development and progression of these disorders.Further studies should be aimed to establish the clinical and prognostic value of peroxidative markers for the CNS diseases considered. This is fundamental for the development of therapeutic interventions antagonizing nitric oxide-related species damage.
本综述聚焦于硝化氧化参与某些神经退行性疾病(帕金森病、阿尔茨海默病、肌萎缩侧索硬化症)、中风以及炎症和自身免疫性疾病(特别关注多发性硬化症)的证据。蛋白质过氧化与上述疾病中观察到的病理变化之间的关系已有报道。尽管许多研究结果来自动物模型和人类患者的尸检标本,但在不同时间和疾病阶段,来自患者脑脊液和血液样本的数据却很少。硝化氧化参与对大脑神经元和其他细胞(即多发性硬化症中的少突胶质细胞)的直接和间接损伤是明确的;但其与这些疾病的发生和发展的相关性则不太明显。进一步的研究应旨在确定所考虑的中枢神经系统疾病中过氧化标志物的临床和预后价值。这对于开发对抗一氧化氮相关物质损伤的治疗干预措施至关重要。